Faculty Highlight – Women’s Cancer Conference, Portland, OR

Meet Dan Veljovich, MD and Selina Liu, MD!

In this week’s faculty highlights, we present Dr. Dan Veljovich and Dr. Selina Liu.

Drs. Dan Veljovich and Selina Liu joined as faculty at the BTF’s Northwest Women’s Cancer Conference in Portland, Oregon on September 17, 2022.

Our staff, Tiani, sat down with Dr. Veljovich and Dr. Liu to discuss their roles in the conference and how they relate to the Binaytara Foundation’s mission of improving access to cancer care through education, advocacy, and innovation.

Dr. Veljovich, an oncologist at Swedish Cancer Institute, hopes to give back by sharing his expertise in ovarian cancer. Dr. Veljovich says he finds the foundation’s mission very compelling.

Dr. Liu is a Hematology/Oncology Fellow at Oregon Health and Science University. Dr. Liu says she was excited to present a case at the BTF’s Northwest Women’s Cancer Conference because it is also an opportunity to learn while sharing knowledge and contributing to the foundation’s goal of educating healthcare providers about the latest developments in the management of cancer.

Watch the video to hear more!

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

5 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

5 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

6 months ago